We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-8.98%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$176M
AUM Growth
-$153M
Cap. Flow
-$123M
Cap. Flow %
-69.91%
Top 10 Hldgs %
94.7%
Holding
34
New
7
Increased
7
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$9.67M
2
PACB icon
Pacific Biosciences
PACB
+$3.38M
3
BHVN icon
Biohaven
BHVN
+$2.91M
4
WGS icon
GeneDx Holdings
WGS
+$2.52M
5
IBRX icon
ImmunityBio
IBRX
+$1.44M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$181M
2
MRNA icon
Moderna
MRNA
+$12.8M
3
CFRX
ContraFect Corporation
CFRX
+$6.05M
4
OPK icon
Opko Health
OPK
+$5.08M
5
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$2.92M

Sector Composition

Rank Sector Weight
1 Healthcare 98.06%
2 Industrials 0.15%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN icon
1
Biohaven
BHVN
$2.07B
$59.3M 33.68%
+401,221
New +$2.91M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$35.7M 20.27%
499,263
– –
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$21.3M 12.13%
305,629
+130,629
+75% +$9.67M
OPK icon
4
Opko Health
OPK
$1.25B
$9.64M 5.48%
5,102,756
-2,150,000
-30% -$5.08M
AGEN
5
Agenus
AGEN
$275M
$9.21M 5.23%
228,830
-8,400
-4% -$428K
PACB icon
6
Pacific Biosciences
PACB
$432M
$8.09M 4.59%
1,393,165
+589,320
+73% +$3.38M
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$2.48B
$8M 4.55%
635,194
+31,200
+5% +$402K
WGS icon
8
GeneDx Holdings
WGS
$1.84B
$7.37M 4.19%
254,664
+55,108
+28% +$2.52M
FORA
9
DELISTED
Forian
FORA
$4.72M 2.68%
1,408,432
+74,955
+6% +$330K
AXDX
10
DELISTED
Accelerate Diagnostics
AXDX
$3.36M 1.91%
220,887
-23,692
-10% -$392K
IMMP
11
Immutep
IMMP
$57M
$2.43M 1.38%
1,557,325
– –
IBRX icon
12
ImmunityBio
IBRX
$7.3B
$1.57M 0.89%
+315,322
New +$1.44M
MRTX
13
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.1M 0.62%
100,000
+39,400
+65% +$2.92M
TQQQ icon
14
ProShares UltraPro QQQ
TQQQ
$30.5B
$966K 0.55%
100,000
-200,000
-67% -$2.92M
DMTK
15
DELISTED
DermTech, Inc. Common Stock
DMTK
$699K 0.4%
176,569
-70,000
-28% -$430K
BIIB icon
16
Biogen
BIIB
$30.4B
$644K 0.37%
2,412
– –
XBI icon
17
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$526K 0.3%
+6,633
New +$559K
CANO
18
DELISTED
Cano Health, Inc.
CANO
$295K 0.17%
+340
New +$213K
BCRX icon
19
CALL
BioCryst Pharmaceuticals
BCRX
$2.48B
$281K 0.16%
250,000
-100,000
-29% -$1.29M
AWH
20
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$271K 0.15%
48,540
– –
VLD
21
DELISTED
Velo3D, Inc.
VLD
$256K 0.15%
1,857
+989
+114% +$129K
IWM icon
22
PUT
iShares Russell 2000 ETF
IWM
$80.4B
$146K 0.08%
+150,000
New +$27.4M
SPY icon
23
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$144K 0.08%
+100,000
New +$39.7M
AGEN
24
CALL
Agenus
AGEN
$275M
$4K ﹤0.01%
+8,437
New +$430K
ACAD icon
25
CALL
Acadia Pharmaceuticals
ACAD
$4.45B
– –
-300,000
Closed -$48K
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Oracle Investment Management held 34 positions worth $176M, down 47% from $329M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Oracle Investment Management withdrew a net $123M in Q3 2022, closing 10 positions and reducing 6 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $181M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Industrials and Energy.

Against the trend, Oracle Investment Management opened a new position in Biohaven worth $59.3M.

  • Oracle Investment Management's largest Q3 2022 buy was Biohaven: 401,221 shares worth $59.3M.
  • Oracle Investment Management added most to Mirati Therapeutics, Inc. Common Stock in Q3 2022, an estimated $9.67M increase.
  • Oracle Investment Management's biggest Q3 2022 reduction was Opko Health, cutting an estimated $5.08M.
  • Oracle Investment Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $181M.
  • Oracle Investment Management's ten largest holdings make up 95% of its $176M portfolio in Q3 2022.
  • Oracle Investment Management opened 7 new positions and closed 10 in Q3 2022.
  • Oracle Investment Management's portfolio value fell 47% quarter-over-quarter to $176M.

Based on Oracle Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.